12/7/2021Sanofi Scores A Trademark Win in China

12/6/2021Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...

12/6/2021Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...

12/6/2021Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...

12/6/2021SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...

12/6/2021Fujifilm Irvine Scientific Establishes Innovation Center in China

12/6/2021Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...

12/6/2021Maximizing China Access for Innovative Therapies (PharmExec)

12/5/2021Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...

12/3/2021BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...

12/3/2021Recent Executive Moves

12/2/2021NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...

12/2/2021WuXi STA and Coherent Biopharma Forms Strategic Partnership 

12/2/2021NHSA and MOHRSS Officially Issue the 2021 NRDL, Adding 74 and Removing...

12/1/2021Innovent and Ascentage Granted NMPA Approval for China's First 3rd Ge...

12/1/2021Genetron and AstraZeneca China Enter Co-Development Agreement for MR...

12/1/2021Novo Nordisk, Sanofi and Eli Lilly Cut Insulin Prices and Lose Share i...

11/30/2021NMPA Issues the Dossier Requirements for Import and Export Permit of N...

11/30/2021NMPA Announces Package Insert Revision of Glycerol Fructose and Sodium...

11/30/2021JPO Releases Final Tender Outcome of the 6th VBP

11/30/2021Jemincare Licenses Kras Inhibitor JMKX1899 to HUYABIO 

11/30/2021Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...

11/30/2021Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

11/30/2021NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...

11/29/2021NHSA Issues Three-Year Action Plan on DRD/DIP Payment System Reform (S...

11/26/2021Luye Subsidiary Boan Bio Signs MOU with Merck to Build Next-Gen Digit...

11/26/2021Simcere Announces CN Conditional Approval of Enweida (Envafolimab) C...

11/26/2021Recent Executive Movements

11/24/2021HUTCHMED and AZ Initiate SACHI P3 Trial of ORPATHYS and TAGRISSO Com...

11/24/2021NMPA Announces Package Insert Revision of Disodium Clodronate Formulat...

Page:76/356 Total number of articles:10680: [First][<<] [74] [75] [76] [77] [78] [>>] [End]